AUTHOR=Liu Hao , Sun Yang , Zhang Xinxin , Li Shiyang , Hu Dong , Xiao Lei , Chen Yanghui , He Lin , Wang Dao Wen 

TITLE=Integrated Analysis of Summary Statistics to Identify Pleiotropic Genes and Pathways for the Comorbidity of Schizophrenia and Cardiometabolic Disease

JOURNAL=Frontiers in Psychiatry

VOLUME=11

YEAR=2020

URL=https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2020.00256

DOI=10.3389/fpsyt.2020.00256

ISSN=1664-0640

ABSTRACT=<p>Genome-wide association studies (GWAS) have identified abundant risk loci associated with schizophrenia (SCZ), cardiometabolic disease (CMD) including body mass index, coronary artery diseases, type 2 diabetes, low- and high-density lipoprotein, total cholesterol, and triglycerides. Although recent studies have suggested that genetic risk shared between these disorders, the pleiotropic genes and biological pathways shared between them are still vague. Here we integrated comprehensive multi-dimensional data from GWAS, expression quantitative trait loci (eQTL), and gene set database to systematically identify potential pleiotropic genes and biological pathways shared between SCZ and CMD. By integrating the results from different approaches including FUMA, Sherlock, SMR, UTMOST, FOCUS, and DEPICT, we revealed 21 pleiotropic genes that are likely to be shared between SCZ and CMD. These genes include <italic>VRK2</italic>, <italic>SLC39A8</italic>, <italic>NT5C2</italic>, <italic>AMBRA1</italic>, <italic>ARL6IP4</italic>, <italic>OGFOD2</italic>, <italic>PITPNM2</italic>, <italic>CDK2AP1</italic>, <italic>C12orf65</italic>, <italic>ABCB9</italic>, <italic>SETD8</italic>, <italic>MPHOSPH9, FES</italic>, <italic>FURIN</italic>, <italic>INO80E</italic>, <italic>YPEL3</italic>, <italic>MAPK3</italic>, <italic>SREBF1</italic>, <italic>TOM1L2</italic>, <italic>GATAD2A</italic>, and <italic>TM6SF2</italic>. In addition, we also performed the gene-set enrichment analysis using the software of GSA-SNP2 and MAGMA with GWAS summary statistics and identified three biological pathways (MAPK-TRK signaling, growth hormone signaling, and regulation of insulin secretion signaling) shared between them. Our study provides insights into the pleiotropic genes and biological pathways underlying mechanisms for the comorbidity of SCZ and CMD. However, further genetic and functional studies are required to validate the role of these potential pleiotropic genes and pathways in the etiology of the comorbidity of SCZ and CMD, which should provide potential targets for future diagnostics and therapeutics.</p>